News

James Johnson Joins the Lab

James Johnson joins the lab as a bioengineering PhD student at the University of Washington (UW). James earned his BS in Chemical Engineering from Texas A&M University. After graduating, he took a job as an R&D Associate Engineer at PepsiCo. After three years of applied science and engineering at PepsiCo, James decided to apply to the Bioengineering PhD program at UW in Seattle so that he could return to working on clinically impactful research.

James’ current research is at the intersection of computational systems biology, the human gut microbiome, aging, and Alzheimer’s disease. In particular, he is interested in understanding how bile acid metabolism (and other microbial metabolic pathways) may contribute to the etiology of neurodegenerative diseases. He will combine computer science, biochemistry, and engineering to answer questions at the nexus of microbial ecology, human health, scientific wellness, and age-related disease.

James was raised in Texas. When he’s not researching and studying, he enjoys drawing and painting, cooking, trying new food and music, traveling outside the country, walking around beautiful Seattle, and spending time with his family and friends.

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • The Gut Microbiome’s Supersized Role In Shaping Our Metabolome

    ISB researchers have shown which blood metabolites are associated with the gut microbiome, genetics, or the interplay between both. Their findings, published in the journal Nature Metabolism, have promising implications for guiding targeted therapies designed to alter the composition of the blood metabolome to improve human health.

  • Seattle Science Foundation and ISB

    ISB and Seattle Science Foundation Partner to Create Video Series

    What are multi-omics? Why does our microbiome matter? What’s the difference between genetics and genomics? What is a digital twin? ISB and Seattle Science Foundation have partnered to create videos answering questions like these and more, showcasing ISB scientists and their work.